Article info
PDFClinical and epidemiological research
Extended report
Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK study
- Correspondence to Dr Walter P Maksymowych, Department of Medicine, University of Alberta, 562 Heritage Medical Research Building, Edmonton, Alberta, Canada T6G 2S2; walter.maksymowych{at}ualberta.ca
Citation
Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK study
Publication history
- Received March 14, 2015
- Revised July 18, 2015
- Accepted July 20, 2015
- First published August 12, 2015.
Online issue publication
October 25, 2017
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
- Data supplement 1 - Online figure S1
- Data supplement 2 - Online table S1
- Data supplement 3 - Online table S2
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/